The main conference will take place February 21-22 and is intended for Institutional Biosafety
Committee (IBC) members and staff and others who have an interest in the oversight of
recombinant DNA research. A major purpose of this event is to promote the professional
development of those associated with IBCs by providing an opportunity to:
- Learn about emerging challenges in the biosafety review and surveillance of
recombinant DNA and related research
- Gain insights into ongoing responsibilities under the NIH Guidelines for Research
Involving Recombinant DNA Molecules
- Discuss special oversight and administrative issues with experts in breakout sessions
- Network with colleagues to share ideas about best practices, resources, innovative
approaches, and possible collaborations
This event will be preceded on February 20 by a half-day training session on the fundamentals of
recombinant DNA oversight. This session is intended for those who are new to this arena or who
would otherwise benefit from a review of Federal and institutional roles and responsibilities. The
faculty will describe the National Institutes of Health (NIH) Office of Biotechnology Activities, the
content of the NIH Guidelines, the responsibilities of IBCs, and other information that all IBC
members and staff should know.
Although primarily targeted at IBC members and staff, the conference and fundamentals training
session also will be of interest to research administrators, biosafety officers, regulatory affairs
officers, and the members and staff of other institutional oversight committees such as
Institutional Review Boards and Institutional Animal Care and Use Committees.
Please note: A modest fee is being charged for the main conference to cover meals, receptions,
and refreshments. The training session is free. Consequently, you must register for each event
separately.
|
